Walk into your renewal knowing what the market pays.
You answer for a number to someone senior, and almost everyone explaining it has a stake in the outcome. This is the same data, published by the plans, in plain English.
Metro market
Colonoscopy
Sacramento-Roseville-Folsom, CA · procedure code 45378
Middle price
$333
Half of this market is above it, half below
Middle half spans
$333 to $486
1.5x from low to high
The expensive end
$486
What the priciest providers charge
Medicare reference · Sacramento-Roseville-Folsom
$418
Performed in an office
$169
Physician fee in a facility
Read this carefully. The facility figure is the physician fee only. When the same service happens in a hospital outpatient department, the hospital bills its own facility payment on top, and that amount is not in this dataset. So the lower number here does not mean the hospital is the cheaper site. It usually is not. We will not publish a total cost by site of service until we hold the facility payment.
Negotiated prices from published filings, reported only where the sample supports it. For your city, not a statewide average. What plans have agreed to pay, not what a patient is billed. Filings as of July 27, 2026.
When it matters
Three moments in your year.
01
Before the renewal presentation
You are about to be told what your increase is and why. Knowing what your market pays for the services that drive your spend changes your questions, before the meeting instead of after.
02
Evaluating a network or a plan design change
Narrower networks, tiering and steering are all sold on price. See the real spread in your metro before anyone models a saving for you.
03
When somebody offers you pharmacy savings
We hold no pharmacy benefit manager contract, no rebate data, no point-of-sale pricing. So we will tell you nothing about your pharmacy benefit. The government collects rebate totals and says in writing it cannot publish them by plan or drug. If someone sells you a pharmacy number from public data, ask which file. The other half of drug spend is public: clinic-administered drugs, infusions and injections, billed under the medical benefit at a filed negotiated rate. Those are in the lookup now, each with its billing unit, because a drug price without one is off by the dose. Each names its carrier and shows the Medicare benchmark, or says we hold none.
04
When someone asks whether you could build your own network
A yes and a boundary. The prices exist, provider by provider, for the plans your market can buy, and nobody building a network has started with the full map. We will not pretend the rest is a data problem. We do not sign contracts, run plans, or help steer patients. We measure. What you build from it is yours, with counsel and an administrator.
05
Answering the CFO
The question is always some version of how do we know this is a good deal. A market figure carrying its filing count and date is an answer you can still defend a year later.
Live, right now
Change it. It is a query, not a screenshot.
A screening colonoscopy in Sacramento. No codes required. The spread inside one market surprises people, and it is the part you can act on.
What you walk out with
A file you can defend.
Not a dashboard you stop opening. A dated, sourced view of what your market pays, readable without a benefits background.
- Plain English throughout. An MRI is called an MRI, with the code behind it as detail, not in front as jargon.
- Your metro, not a national or state average, because the market you buy care in is local.
- A Medicare reference beside each service, which is the comparison most finance teams already understand.
- The source, the filing count and the filings date printed on every figure.
- An explicit statement of what the data cannot tell you, so nothing in your file overstates what you knew at the time.
Before you ask
We are a price dataset, and we are not your advisor.
We hold what plans contracted to pay providers. We do not hold your claims, enrollment or utilization, so we cannot project your spend, model your renewal, or say what a plan change would save. We hold no protected health information and there is no path for any to enter this product. Nothing here is legal, actuarial or benefits advice. It lets you see the market for yourself, from the filings, with the source attached.